TITLE

Pediatric Erosive Esophagitis Maintenance: Finally, Some Level 1 Evidence!

AUTHOR(S)
Orenstein, Susan R.
PUB. DATE
June 2007
SOURCE
American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1298
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
In children, as in adults, gastroesophageal reflux disease (GERD), particularly erosive esophagitis, is now believed to be a chronic disease, probably requiring lifelong maintenance therapy. However, this assumption has not received adequate clinical testing, and the provocative article by Boccia et al. in this issue of the Journal challenges it. The strengths of this exceptional pediatric study lie in its prospective, controlled, randomized character, and in its relatively long duration of prospective follow-up. Weaknesses of the study include its limited power and lack of prior validation of outcome measures. The conclusions of the study are applicable only to children without chronic neurologic, respiratory, or congenital esophageal abnormalities, the children for whom chronic proton pump inhibitors (PPIs) are most often required. The study's provocative results might be explained by the fundamental lack of GERD chronicity in otherwise healthy children, combined with absence of the PPI dependence that can be produced when PPIs are used chronically for chronic disease.
ACCESSION #
25137409

 

Related Articles

  • Current Pharmacological Management of Gastro-Esophageal Reflux in Children. Tighe, Mark P.; Afzal, Nadeem A.; Bevan, Amanda; Beattie, R. Mark // Pediatric Drugs;2009, Vol. 11 Issue 3, p185 

    Gastro-esophageal reflux (GER) is a common phenomenon, characterized by the regurgitation of the gastric contents into the esophagus. Gastro-esophageal reflux disease (GERD) is the term applied when GER is associated with sequelae or faltering growth. The main aims of treatment are to alleviate...

  • Managing gastro-oesophageal reflux in infants.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/4/2010, Vol. 341 Issue 7771, p495 

    A reprint of the article "Managing Gastro-Oesophageal Reflux in Infants," which appeared in a 2009 issue of "Drug and Therapeutics Bulletin" is presented. It offers information on gastro-oesophageal reflux disease (GORD) in infants, including its diagnosis and treatment principles. It recommends...

  • Population Pharmacokinetics of Rabeprazole and Dosing Recommendations for the Treatment of Gastroesophageal Reflux Disease in Children Aged 1-11 Years. McLeay, Sarah; Green, Bruce; Treem, William; Thyssen, An; Mannaert, Erik; Kimko, Holly // Clinical Pharmacokinetics;Oct2014, Vol. 53 Issue 10, p943 

    Background and Objective: Rabeprazole sodium is a proton pump inhibitor used for the treatment of gastroesophageal reflux disease (GERD). The objective of this study was to develop a population pharmacokinetic model for rabeprazole that describes concentration-time data arising from phase I and...

  • Gastroesophageal Reflux Disease and a HAPPI Quality of Life. Johnston, Brian T. // American Journal of Gastroenterology;Jul1999, Vol. 94 Issue 7, p1723 

    Comments on the role of heartburn merit proton pump inhibitors in improving the quality of life of patients with heartburn. Performance of esophageal pH monitoring as part of he protocol; Need for placebo-controlled approach to trials of treatment for heartburn; Improvement of the quality of...

  • Symptomatic and endoscopic outcome of heartburn 3—4.5 years after starting lansoprazole therapy: a prospective study of 142 patients. Farsakh, Niazy Abu // Journal of Gastroenterology;2003, Vol. 38 Issue 11, p1042 

    Background Methods. All patients who were referred to the gastroenterology clinic at the University Health Center to evaluate their heartburn and who met the inclusion criteria were included in the present study. Symptomatic and endoscopic evaluations were carried out and then they were started...

  • Second opinion.  // Mayo Clinic Health Letter;APr2015, Vol. 33 Issue 4, p8 

    The article provides an answer to the question of whether there are any risks in taking a proton pump inhibitor.

  • Goblins Go "Owwww". Gupta, Sanjay // Time;11/3/2003, Vol. 162 Issue 18, p99 

    Discusses how children who eat too much candy may suffer from gastroesophageal reflux disease (GERD). How the disease causes heartburn and stomach aches; Development of problems such as pneumonia or esophageal cancer; How parents can treat children with GERD.

  • Treat gastro-oesophageal reflux disease aggressively in children with asthma.  // Drugs & Therapy Perspectives;Apr2006, Vol. 22 Issue 4, p5 

    Gastro-oesophageal reflux disease (GORD) and asthma appear to be linked, although the clinical relevance of this link has not been clarified. Overall, clinical trials of medical and surgical intervention in children with GORD coexisting with asthma have consistently improved asthma symptoms,...

  • Proton Pump Inhibitors for Kids, Too. Mack, D.; Thompson, Jon S. // American Journal of Gastroenterology;May2001, Vol. 96 Issue 5, p1333 

    Presents the results of a study on the use of omeprazole for treatment of chronic erosive esophagitis in children. Comparison of the drug's dosage for children with the dosage for adults; Link between the proton pump inhibitor's dosage and the severity of the esophagitis; Safety and efficacy of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics